We are hereby pleased to report that the above referenced patent application has received a Notice of Allowance, indicating that the claims presently on file are allowable.

Our unique ex vivo model described in the USA application “Methods employing insect models for determining intestinal absorption of chemical compounds” is a valuable tool to determinate the profiling of chemical compounds in the early drug discovery process.

The ex vivo models enables drug discovery companies with the opportunity to obtain reproducible quality data fast to identify lead compounds or areas of adjustments to potential compounds at at reasonable price.